Moral Psychology and the Intuition that Pharmaceutical Companies Have a 'Special' Obligation to Society

被引:8
作者
Huebner, James M. [1 ]
机构
[1] Suffolk Univ, Dept Philosophy, Boston, MA 02108 USA
关键词
Access to lifesaving medicines; Betrayal aversion; Moral intuition; Moral psychology; Pharmaceutical industry; Special moral obligation; Taboo trade-off theory; INDUSTRY; DRUGS; ROFECOXIB; HEALTH; FORMS;
D O I
10.1007/s10551-013-1773-4
中图分类号
F [经济];
学科分类号
02 ;
摘要
Many people believe that the research-based pharmaceutical industry has a 'special' moral obligation to provide lifesaving medications to the needy, either free-of-charge or at a reduced rate relative to the cost of manufacture. In this essay, I argue that we can explain the ubiquitous notion of a special moral obligation as an expression of emotionally charged intuitions involving sacred or protected values and an aversive response to betrayal in an asymmetric trust relationship. I then review the most common arguments used to justify the claim that the pharmaceutical industry has a special moral obligation and show why these justifications fail. Taken together, these conclusions call into question the conventional ideologies that have traditionally animated the debate on whether the pharmaceutical industry has special duties of beneficence and distributive justice with respect to the impoverished in dire need of their products.
引用
收藏
页码:501 / 510
页数:10
相关论文
共 84 条
[1]   The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts [J].
Abboud, Camille ;
Berman, Ellin ;
Cohen, Adam ;
Cortes, Jorge ;
DeAngelo, Daniel ;
Deininger, Michael ;
Devine, Steven ;
Druker, Brian ;
Fathi, Amir ;
Jabbour, Elias ;
Jagasia, Madan ;
Kantarjian, Hagop ;
Khoury, Jean ;
Laneuville, Pierre ;
Larson, Richard ;
Lipton, Jeffrey ;
Moore, Joseph O. ;
Mughal, Tariq ;
O'Brien, Susan ;
Pinilla-Ibarz, Javier ;
Quintas-Cardama, Alfonso ;
Radich, Jerald ;
Reddy, Vishnu ;
Schiffer, Charles ;
Shah, Neil ;
Shami, Paul ;
Silver, Richard T. ;
Snyder, David ;
Stone, Richard ;
Talpaz, Moshe ;
Tefferi, Ayalew ;
Van Etten, Richard A. ;
Wetzler, Meir ;
Abruzzese, Elisabetta ;
Apperley, Jane ;
Breccia, Massimo ;
Byrne, Jenny ;
Cervantes, Francisco ;
Chelysheva, Ekaterina ;
Clark, R. E. ;
de Lavallade, Hugues ;
Dyagil, Iryna ;
Gambacorti-Passerini, Carlo ;
Goldman, John ;
Haznedaroglu, Ibrahim ;
Hjorth-Hansen, Henrik ;
Holyoake, Tessa ;
Huntly, Brian ;
le Coutre, Philipp ;
Lomaia, Elza .
BLOOD, 2013, 121 (22) :4439-4442
[2]  
ADAMS M. O, 2006, J BUSINESS EC RES, V4, P85
[3]  
Almashat S., 2010, Rapidly Increasing Criminal and Civil Monetary Penalties Against the Pharmaceutical Industry: 1991 to 2010
[4]  
Angell M., 2004, TRUTH DRUG CO
[5]   Industry-sponsored clinical research - A broken system [J].
Angell, Marcia .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (09) :1069-1071
[6]  
[Anonymous], 2011, FORTUNE MAGAZINE
[7]  
[Anonymous], 1994, New York Times
[8]  
[Anonymous], NY TIMES
[9]  
[Anonymous], 2012, The Economist
[10]  
[Anonymous], 1861, UTILITARIANISM